{"id":649,"date":"2026-02-27T08:36:54","date_gmt":"2026-02-27T08:36:54","guid":{"rendered":"http:\/\/localhost:8881\/2026\/02\/27\/behind-generates-feverish-race-to-raise-400m-ipo-while-window-remains-open-fierce-biotech\/"},"modified":"2026-02-27T08:36:54","modified_gmt":"2026-02-27T08:36:54","slug":"behind-generates-feverish-race-to-raise-400m-ipo-while-window-remains-open-fierce-biotech","status":"publish","type":"post","link":"https:\/\/flamenet.io\/2026\/02\/27\/behind-generates-feverish-race-to-raise-400m-ipo-while-window-remains-open-fierce-biotech\/","title":{"rendered":"Behind Generate’s ‘feverish’ race to raise $400M IPO while window remains open – Fierce Biotech"},"content":{"rendered":"
    \n
  1. Behind Generate’s ‘feverish’ race to raise $400M IPO while window remains open<\/a>  Fierce Biotech<\/font><\/li>\n
  2. Generate Biomedicines shares fall in weak Nasdaq debut for drug developer<\/a>  Reuters<\/font><\/li>\n
  3. Generate caps a strong month for biotech IPOs with $400M offering<\/a>  BioPharma Dive<\/font><\/li>\n
  4. Flagship-Backed Generate Biomedicines Raises $400 Million in IPO<\/a>  Yahoo Finance<\/font><\/li>\n
  5. Generate:Biomedicines Rings the Opening Bell<\/a>  Nasdaq<\/font><\/li>\n<\/ol>\n","protected":false},"excerpt":{"rendered":"

    Behind Generate’s ‘feverish’ race to raise $400M IPO while window remains open  Fierce Biotech Generate Biomedicines shares fall in weak Nasdaq debut for drug developer  Reuters Generate… [more]<\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[70],"tags":[],"class_list":["post-649","post","type-post","status-publish","format-standard","hentry","category-news"],"_links":{"self":[{"href":"https:\/\/flamenet.io\/api\/wp\/v2\/posts\/649","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flamenet.io\/api\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flamenet.io\/api\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flamenet.io\/api\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flamenet.io\/api\/wp\/v2\/comments?post=649"}],"version-history":[{"count":0,"href":"https:\/\/flamenet.io\/api\/wp\/v2\/posts\/649\/revisions"}],"wp:attachment":[{"href":"https:\/\/flamenet.io\/api\/wp\/v2\/media?parent=649"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flamenet.io\/api\/wp\/v2\/categories?post=649"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flamenet.io\/api\/wp\/v2\/tags?post=649"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}